Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction

J Am Coll Cardiol. 2024 Apr 9;83(14):1348-1350. doi: 10.1016/j.jacc.2024.01.033.
No abstract available

Publication types

  • Letter

MeSH terms

  • Glucagon-Like Peptide 1
  • Heart Failure* / drug therapy
  • Humans
  • Obesity / complications
  • Stroke Volume
  • Ventricular Function, Left

Substances

  • Glucagon-Like Peptide 1